Accession Number: | 0001179110-20-008891 |
Date: | 2020-08-07 |
Issuer: | AVADEL PHARMACEUTICALS PLC (AVDL) |
Original Submission Date: |
GLASS GEOFFREY MICHAEL
C/O AVADEL PHARMACEUTICALS PLC
BLOCK 10-1 BLANCHARDSTOWN CORP. PARK
DUBLIN, L2 15
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 8.48 | 2020-08-07 | deemed execution date | A | 42,000 (a) | 2020-08-07 | adss 42,000 | $8.48 | 42,000 | direct |
ID | footnote |
---|---|
f1 | options become exercisable as to 14,000 adss on each of the first three anniversaries after the 08/07/2020 grant date. |
f2 | the issuer's "adss" are american depositary shares, with each ads representing one ordinary share, nominal value $0.01 per share, of the issuer; adss may be represented by americandepositary receipts. |